1-6 of 6
Reiji Fukano
Close
Sort by
Journal Articles

Prognostic Impact of Minimal Disseminated Disease By Digital PCR for Pediatric ALK-Positive Anaplastic Large Cell Lymphoma

Reiji Fukano, Yuka Iijima-Yamashita, Hideto Iwafuchi, Atsuko Nakazawa, Akiko Moriya Saito, Tetsuya Takimoto, Masahiro Sekimizu, Yutaka Suehiro, Shunji Hasegawa, Tetsuya Mori, Keizo Horibe
Journal: Blood
Blood (2022) 140 (Supplement 1): 3506–3507.
https://doi.org/10.1182/blood-2022-158364
Published: 2022
Journal Articles

Modeling and targeting of erythroleukemia by hematopoietic genome editing

Ilaria Iacobucci, Chunxu Qu, Elena Varotto, Laura J. Janke, Xu Yang, Aman Seth, Anang Shelat, Jake D. Friske, Reiji Fukano, Jiyang Yu, Burgess B. Freeman, III, James A. Kennedy, Adam S. Sperling, Rena Zheng, Yingzhe Wang, Harini Jogiraju, Kirsten M. Dickerson, Debbie Payne-Turner, Sarah M. Morris, Emily S. Hollis, Nina Ghosn, Georgia E. Haggard, R. Coleman Lindsley, Benjamin L. Ebert, Charles G. Mullighan
Journal: Blood
Blood (2021) 137 (12): 1628–1640.
https://doi.org/10.1182/blood.2020009103
Published: 2021
Includes: Supplemental data
Journal Articles

Phase II Trial of CH5424802 (alectinib hydrochloride) for Recurrent or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Masahiro Sekimizu, MD PhD, Reiji Fukano, MD PhD, Ilseung Choi, MD PhD, Akiko Kada, PhD, Akiko Saito, MD, Ryuta Asada, PhD, Tetsuya Mori, MD PhD, Hirokazu Nagai, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2924.
https://doi.org/10.1182/blood-2018-99-112708
Published: 2018
Journal Articles

Outcome of 136 Children with Advanced Lymphoblastic Lymphoma Receiving an BFM-Type Therapy with Intensified Maintenance: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Shosuke Sunami, MD, PhD, Masahiro Sekimizu, MDPhD, Tetsuya Takimoto, MD,PhD, Tetsuya Mori, MD,PhD, Tetsuo Mitsui, MD, PhD, Reiji Fukano, MD, PhD, Takeshi Mori, MD, PhD, Atsushi Kikuta, MD PhD, Koh Katsuyoshi, MD,PhD, Toshihiko Imamura, MD, PhD, Akiko Moriya Saito, MD, PhD, Tomoyuki Watanabe, PhD, Kouichi Ohshima, MD, PhD, Junichiro Fujimoto, MD, PhD, Atsuko Nakazawa, MD, PhD, Ryoji Kobayashi, MD, PhD, Keizo Horibe, MD, Masahito Tsurusawa, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 3049.
https://doi.org/10.1182/blood.V124.21.3049.3049
Published: 2014
Journal Articles

The Clinical Features and Prognosis of Early T-Cell Precursor Subtype of Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Reiji Fukano, MD PhD, Shosuke Sunami, MD PhD, Masahiro Sekimizu, MDPhD, Tetsuya Takimoto, Tetsuya Mori, MDPhD, Tetsuo Mitsui, MD PhD, Takeshi Mori, MD, PhD, Akiko Moriya Saito, MD PhD, Tomoyuki Watanabe, Koichi Ohshima, Junichiro Fujimoto, MD PhD, Atsuko Nakazawa, MD PhD, Nobutaka Kiyokawa, MD PhD, Ryoji Kobayashi, MD PhD, Keizo Horibe, MD PhD, Masahito Tsurusawa, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1728.
https://doi.org/10.1182/blood.V124.21.1728.1728
Published: 2014
Journal Articles

Differentiating Burkitt Lymphoma from Burkitt-like Lymphoma in Pediatrics: Report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study

Tomoo Osumi, MD, Masahiro Sekimizu, MDPhD, Tetsuya Mori, MDPhD, Reiji Fukano, MD, Yuhki Koga, MDPhD, Jun-ichi Ueyama, MDPhD, Fumiko Tanaka, MD, Kentaro Ohki, MD PhD, Tetsuo Mitsui, MD PhD, Takeshi Mori, MD PhD, Shosuke Sunami, MD PhD, Akiko Kada, MPH, Akiko Moriya Saito, MD PhD, Keizo Horibe, MD PhD, Katsuyoshi Koh, MD, Yoshihiro Komada, MD PhD, Yoshiyuki Kosaka, MD, Koichi Ohshima, Atsuko Nakazawa, MD PhD, Masahito Tsurusawa, MD PhD, Ryoji Kobayashi, MD PhD, Souichi Adachi, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1651.
https://doi.org/10.1182/blood.V124.21.1651.1651
Published: 2014